The safety of ranitidine bismuth citrate in controlled clinical studies

Pharmacoepidemiology and Drug Safety

Volumn 5, Issue 6, 1996, Pages 399-407

  Pipkin, Graham A ^a   Mills, Jane G ^a   Kler, Lata ^a   Dixon, Jonathon S ^a   Wood, John R ^a  

^a GLAXOSMITHKLINE   (United Kingdom)

Author keywords

bismuth; controlled clinical trial; Helicobacter pylori; peptic ulcer; ranitidine; safety

Indexed keywords

RANITIDINE BISMUTH CITRATE;

ADVERSE DRUG REACTION; ARTICLE; CLINICAL TRIAL; CONSTIPATION; DIARRHEA; DRUG SAFETY; DRUG TOLERANCE; HEADACHE; HUMAN; MORTALITY; NAUSEA; PHARMACOEPIDEMIOLOGY; PRESCRIPTION; PRIORITY JOURNAL; RESPIRATORY TRACT INFECTION; VERTIGO; VOMITING;

EID: 0030512353     PISSN: 10538569     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1099-1557(199611)5:6<399::AID-PDS243>3.0.CO;2-4     Document Type: Article

References (27)

1. McColm, A. A., McLaren, A., Klinkert, G., et al. Ranitidine bismuth citrate: a novel anti-ulcer agent with different physico-chemical characteristics and improved biological activity to a bismuth citrate - ranitidine admixture. Alimentary Pharmacology and Therapeutics 1996; 10: 241-250.
2. Anon. Ranitidine bismuth citrate. Drugs Future 1995; 20: 480-482.
3. Stables, R., Campbell, C. J. C., Clayton, N. M., et al. Gastric anti-secretory, mucosal protective, anti-pepsin and anti-Helicobacter properties of ranitidine bismuth citrate. Alimentary Pharmacology and Therapeutics 1993; 7: 237-246.
4. Bardhan, K. D., Dekkers, C. P. M., Lam, S. K., et al. GR122311X (ranitidine bismuth citrate), a new drug for the treatment of duodenal ulcer. Alimentary Pharmacology and Therapeutics 1995; 9: 497-506.
5. Forssell, H., Nowak, A., Tildesley, G., et al. Comparison of GR122311X (ranitidine bismuth citrate) with ranitidine hydrochloride for the treatment of duodenal ulcer. Gut 1995; 37 (suppl. 2): A41.
6. Bailey, R. J., Maricz, K., Roesch, W., et al. GR122311X (ranitidine bismuth citrate) a new drug for the treatment of gastric ulcer. Gastroenterology 1995; 108: A51.
7. Bardhan, K. D., Dallaire, C., Eisold, H. and Duggan, A. E. The treatment of duodenal ulcer with GR122311X (ranitidine bismuth citrate) and clarithromycin. Gut 1995; 37 (suppl. 1): A5.
8. Peterson, W. L., Ciociola, A. A., Sykes, D., McSorely, D. J., Webb, D. D. and the RBC H. pylori study group. Ranitidine bismuth citrate plus clarithromycin is effective for healing duodenal ulcers, eradicating H. pylori and reducing ulcer recurrence. Alimentary Pharmacology and Therapeutics 1996; 10: 251-261.
9. Pounder, R. E., Bailey, R., Louis, J. A., Ohlin, B., Dixon, M. F. and Quirke, P. GR122311X (ranitidine bismuth citrate) with clarithromycin for the eradication of Helicobacter pylori. Gut 1995; 37 (suppl. 1): A42.
10. Lanza, F., Ciociola, A. A., Sykes, D., Heath, A., McSorley, D. J. and Webb, D. D. Ranitidine bismuth citrate plus clarithromycin is effective in eradicating H. pylori, healing duodenal ulcers, and preventing ulcer relapse. Gastroenterology 1996; 110: A172.
11. Butruk, E., Ching, C. K., Schutze, K. and Duggan, A. E. The treatment of duodenal ulcer with GR122311X (ranitidine bismuth citrate) and amoxycillin. Gut 1995; 37 (suppl. 1): A42.
12. O'Morain, C., Schulz, T. B., Tam, C-Y., Dixon, M. F., Quirke, P. and Duggan, A. E. GR122311X (ranitidine bismuth citrate) with amoxycillin for the eradication of Helicobacter pylori. Gut 1995; 37 (suppl. 1): A42.
13. Wormsley K. G. Safety profile of ranitidine. A review. Drugs 1993; 46: 976-985.
14. Vial, T., Goubier, C., Bergeret, A., Cabrera, F., Evreux, J. C. and Descotes, J. Side effects of ranitidine. Drug Safety 1991; 6: 94-117.
15. Wyeth, J. W., Pounder, R. E., Duggan, A. E., et al. The safety and efficacy of ranitidine bismuth citrate in combination with antibiotics for eradication of Helicobacter pylori. Alimentary Pharmacology and Therapeutics 1996; 10: 623-630.
16. Logan, R. P. H., Gummett, P. A., Misiewicz, J. J., et al. The efficacy of ranitidine bismuth citrate (GR122311X) in the treatment of Helicobacter pylori infection. Gastroenterology 1992; 104: A114.
17. Haeck, P. W., Peixe, G. R., van Rensburg, C., Dallaire, C., Scrimgeour, D. and Lotay, N. Effects of food on duodenal ulcer healing and H. pylori eradication during treatment with GR122311X (ranitidine bismuth citrate). Gut 1995; 37 (suppl. 2): A41.
18. Hervet, E., Barrat, J., Darbois, Y., Faguer, C. and Veron, P. Encephalopathie aigue bismuthique chez une femme enceinte. Naissance d'un enfant normal. La Nouvelle Presse médicale. 1975; 4: 2274-2275.
19. Cambier, J., Le Bigot, P., Thoyer-Rozat., Irondelle, D. and Levardon, M. Encephalopathie bismuthique chez une femme enceinte. Naissance d'un enfant normal. La Nouvelle Presse médicale 1995; 4: 2275.
20. Quereux, C., Morice, J., Level, G., Ezes, H. and Wahl, P. L'encephalopathie bismuthique chez la femme enceinte. A propos d'une observation. Journal of Gynecology Obstetrics and the Biology of Reproduction 1976; 5: 97-103.
21. Lacey, L. F., Douglas, J., Duggan, A., Lotay, N., Roberts, P. M. and Kler, L. Trough plasma bismuth concentrations in peptic ulcer patients treated with ranitidine bismuth citrate (GR122311X). Gastroenterotogy 1996; 110: A166.
22. Koch, K. M., Kerr, B. M., Gooding, A. E. and Davis, I. M. Pharmacokinetics of bismuth and ranitidine following multiple doses of ranitidine bismuth citrate. British Journal of Clinical Pharmacology in press.
23. Winship, K. A. Toxicity of bismuth salts. Adverse Drug Reactions and Acute Poisoning Reviews 1983; 2: 103-121.
24. ®. Digestion 1987; 37 (suppl. 2): 53-59.
25. Slikkerveer, A. and de Wolff, F. A. Pharmacokinetics and toxicity of bismuth compounds. Medical Toxicology and Adverse Drug Experiences 1989; 4: 303-323.
26. Marshall, B. J., Lewis, J. H., Fisher, R. L., et al. The use of bismuth in gastroenterology. American Journal of Gastroenterology 1991; 86: 16-25.
27. Menge, H., Gregor, M., Brosius, B., Hopert, R. and Lang, A. Pharmacology of bismuth. European Journal of Gastroenterology and Hepatology 1992; 4 (suppl. 2): S41-S47.